Mo1750 RISK-BENEFIT ASSESSMENT OF IBD DRUGS: A PHYSICIANS AND PATIENTS SURVEYFerdinando D’Amico,Bénédicte Caron,Sophie Vieujean,Laurent Peyrin–Biroulet,Silvio DaneseGastroenterology(2023)引用 0|浏览0暂无评分关键词ibd drugs,risk-benefitAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要